NP220 Activators
NP220 activators revolve around the intricate processes of adipogenesis and transcriptional regulation. A notable subset of chemicals in this cadre are the PPARγ agonists, like Rosiglitazone, Troglitazone, and GW1929. These compounds stimulate the peroxisome proliferator-activated receptor gamma (PPARγ), a pivotal regulator of adipogenesis. By kindling this pathway, they pave the way for indirect NP220 activation, given its role in adipogenic processes.
Another cluster of activators centers on the modulation of cAMP levels, a ubiquitous secondary messenger. Both Forskolin and IBMX hike cAMP levels, with Forskolin doing so by igniting adenylate cyclase and IBMX by thwarting phosphodiesterases. Elevated cAMP levels can stir various signaling cascades that might involve NP220. Meanwhile, agents like Dexamethasone and Retinoic acid, by influencing adipocyte differentiation, create a cellular context conducive to NP220 activation. Additionally, factors such as Wnt3a, TGF-beta, BMP7, and C/EBP alpha navigate the adipogenesis landscape, subtly steering the cell towards states where NP220 might be more active.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
An agonist of PPARγ, it can stimulate adipogenesis, which in turn might influence NP220 activation. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
Another PPARγ agonist, potentially influencing NP220 via adipogenesis stimulation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, raising cAMP levels which can indirectly activate NP220 through signaling pathways. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid that can promote adipogenesis, potentially stimulating NP220 activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that raises cAMP levels, potentially influencing NP220 indirectly. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences adipocyte differentiation, potentially activating NP220 indirectly. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Key adipogenic factor that can stimulate pathways where NP220 might be active. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $70.00 | 30 | |
PPARγ agonist that might activate NP220 indirectly through stimulation of adipogenesis. | ||||||